Natixis Advisors LLC Acquires 3,077 Shares of Veeva Systems Inc. (NYSE:VEEV)

Natixis Advisors LLC raised its holdings in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 108,803 shares of the technology company's stock after acquiring an additional 3,077 shares during the period. Natixis Advisors LLC owned approximately 0.07% of Veeva Systems worth $22,876,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB raised its position in Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Centricity Wealth Management LLC bought a new position in shares of Veeva Systems during the 4th quarter valued at about $25,000. Smithfield Trust Co raised its holdings in shares of Veeva Systems by 145.5% during the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock valued at $27,000 after buying an additional 80 shares in the last quarter. True Wealth Design LLC lifted its position in Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock worth $29,000 after buying an additional 135 shares during the last quarter. Finally, Retirement Wealth Solutions LLC purchased a new stake in Veeva Systems in the fourth quarter worth approximately $31,000. Hedge funds and other institutional investors own 88.20% of the company's stock.

Veeva Systems Stock Up 0.5 %

Shares of NYSE:VEEV traded up $1.13 during trading on Friday, hitting $236.98. The stock had a trading volume of 1,192,386 shares, compared to its average volume of 1,008,032. Veeva Systems Inc. has a 12 month low of $170.25 and a 12 month high of $258.93. The company has a market capitalization of $38.47 billion, a PE ratio of 58.51, a PEG ratio of 1.89 and a beta of 0.88. The firm's fifty day moving average is $228.86 and its 200 day moving average is $222.03.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Stifel Nicolaus boosted their price objective on shares of Veeva Systems from $240.00 to $272.00 and gave the stock a "buy" rating in a report on Friday, December 6th. Stephens reissued an "overweight" rating and issued a $280.00 price target on shares of Veeva Systems in a research note on Thursday, March 6th. Morgan Stanley upped their price target on shares of Veeva Systems from $195.00 to $201.00 and gave the company an "underweight" rating in a research report on Thursday, March 6th. Needham & Company LLC reiterated a "buy" rating and issued a $270.00 price objective on shares of Veeva Systems in a report on Thursday, March 6th. Finally, KeyCorp dropped their target price on Veeva Systems from $285.00 to $255.00 and set an "overweight" rating for the company in a report on Wednesday, January 8th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Veeva Systems has an average rating of "Moderate Buy" and an average target price of $256.52.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.